We develop rapid and reliable diagnostic solutions that enable early detection and precise identification of infectious agents. Our technologies are designed to support timely clinical decisions, improve patient outcomes, and strengthen public health response.
To combat the rising threat of multidrug-resistant pathogens, we actively pursue the discovery and development of novel antimicrobial compounds. Our research efforts focus on improving treatment effectiveness and safeguarding global health.
We also offer specialized design, formulation, and production of custom laboratory products tailored to unique scientific workflows. These high-quality solutions support research organizations and industry partners across a wide range of applications.

Our expertise span a broad range of microbiology-driven research initiatives, integrating both in vitro (cell culture and various laboratory assay platforms) and in vivo (animal model) systems. These services allow clients to accelerate their R&D efforts without the need for significant investment in specialized equipment or facilities.
- In Vitro Testing: We employ sophisticated molecular assays, cell-based systems, and high-precision analytical techniques to investigate pathogen behavior, evaluate drug efficacy and toxicity, and analyze resistance mechanisms in controlled laboratory environments.
- In Vivo Studies: We offer access to a diverse portfolio of validated animal models to assess drug safety, pharmacology, and therapeutic effectiveness in living organisms—an essential step toward regulatory approval and clinical trial readiness. All study designs can be customized to meet the specific objectives of your research program.
1010 Rockville Pike, Rockville, MD, USA
Tel: 301-660-4591 E-mail: info@microbiologyassociatesllc.com
Monday - Friday: 9:00am - 5:00pm
Saturday - Sunday: Closed